These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3871341

  • 1. Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin.
    Casellas P, Canat X, Fauser AA, Gros O, Laurent G, Poncelet P, Jansen FK.
    Blood; 1985 Feb; 65(2):289-97. PubMed ID: 3871341
    [Abstract] [Full Text] [Related]

  • 2. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC, Youle RJ, Vallera DA.
    Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
    [Abstract] [Full Text] [Related]

  • 3. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA.
    Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347
    [Abstract] [Full Text] [Related]

  • 4. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
    Douay L, Gorin NC, Lopez M, Casellas P, Liance MC, Jansen FK, Voisin GA, Baillou C, Laporte JP, Najman A.
    Cancer Res; 1985 Jan; 45(1):438-41. PubMed ID: 3880666
    [Abstract] [Full Text] [Related]

  • 5. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM.
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [Abstract] [Full Text] [Related]

  • 6. T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
    Casellas P, Ravel S, Bourrié BJ, Derocq JM, Jansen FK, Laurent G, Gros P.
    Blood; 1988 Oct; 72(4):1197-202. PubMed ID: 3262384
    [Abstract] [Full Text] [Related]

  • 7. Reconstitution of hematopoiesis after bone marrow purging with ricin A chain immunotoxin.
    Fauser AA, Kanz L, Casellas P, Laurent G, Cooper BA, Löhr GW.
    Transplantation; 1986 Mar; 41(3):356-60. PubMed ID: 3485318
    [Abstract] [Full Text] [Related]

  • 8. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
    Myers CD, Thorpe PE, Ross WC, Cumber AJ, Katz FE, Tax W, Greaves MF.
    Blood; 1984 May; 63(5):1178-85. PubMed ID: 6370334
    [Abstract] [Full Text] [Related]

  • 9. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M, Schlick E, Waldmann TA, Vitetta ES, Greene WC.
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [Abstract] [Full Text] [Related]

  • 10. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
    Fauser AA, Shustik C, Langleben A, Laurent G, Kanz L, Spurll GM, Price G, Ahlgren PD, Cooper BA.
    Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672
    [Abstract] [Full Text] [Related]

  • 11. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 12. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
    Preijers FW, De Witte T, Wessels JM, De Gast GC, Van Leeuwen E, Capel PJ, Haanen C.
    Blood; 1989 Aug 15; 74(3):1152-8. PubMed ID: 2473811
    [Abstract] [Full Text] [Related]

  • 13. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bregni M, Bonnadonna G, Gianni AM.
    Blood; 1987 Jan 15; 69(1):345-8. PubMed ID: 3098324
    [Abstract] [Full Text] [Related]

  • 14. Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells.
    Roy DC, Griffin JD, Belvin M, Blättler WA, Lambert JM, Ritz J.
    Blood; 1991 Jun 01; 77(11):2404-12. PubMed ID: 2039821
    [Abstract] [Full Text] [Related]

  • 15. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
    Youle RJ, Uckun FM, Vallera DA, Colombatti M.
    J Immunol; 1986 Jan 01; 136(1):93-8. PubMed ID: 3079613
    [Abstract] [Full Text] [Related]

  • 16. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
    Leonard JE, Taetle R, To D, Rhyner K.
    Blood; 1985 May 01; 65(5):1149-57. PubMed ID: 3888307
    [Abstract] [Full Text] [Related]

  • 17. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM, Buchsbaum DJ, Azemove SM, Hanna DE, Vallera DA.
    J Immunol; 1986 Jun 15; 136(12):4721-8. PubMed ID: 3086441
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.